Vaccine Genetically Engineers People to Stop Smoking: Planned for Children

 Credit: iStockphoto

'An upcoming vaccine contains a genetically engineered virus designed to infect the liver, forcing it to make antibodies against nicotine. In other words, its purpose is to genetically engineer humans to control behavior.

They’re already talking about giving it to children.

'The vaccine contains a virus genetically engineered to carry an artificial anti-nicotine antibody called NIC9D9.The genetically engineered virus is called AAVantiNic.

After injection, its purpose is to infect the liver, forcing DNA changes that result in production of NIC9D9.

If it works as planned, this genetic change will be permanent. This is not like most disease vaccines, which cause the body to create antibodies against an injected substance. The artificial nature of that process results in the antibody production being temporary, thus requiring repeat doses of the vaccine.'

Read more...

Read more »

Lobelia Inflata

 

'One of the most powerful and effective medicinal ingredients is respiratory stimulant Lobelia extract.  Lobelia works in two wonderful ways for respiratory conditions as both an antispasmodic and expectorant.  It helps reduce bronchial asthma and coughing attacks (antispasmodic) and helps expel mucous in the lungs (expectorant).

This cough suppressant and relaxant is also beneficial for those with fever and cold symptoms. 

Lobelia is high in manganese, vitamin A (needed for tissue repair) and C (immunostimulant), and alkaloids (gums, resins, lipids, essential oil and lobelic acid).

Working to stimulate the brain stem Lobelia produces stronger and deeper breathing.

Due to its high piperidine alkaloid content (imitating the effects of nicotine) it is also beneficial for those trying to quit smoking.'

Read more...

Read more »

Who Would Fall For This Dangerous Hoax? -- Vaccine for Smokers

'Smokers may soon be able to break their habit with an injectable vaccine that prevents nicotine in tobacco entering the brain, where it creates a highly addictive sensation of pleasure. The NicVAX vaccine moved closer to the market on Monday after a deal between GlaxoSmithKline and the US biotech company Nabi Pharmaceuticals, which developed the product.'

Read more...

Read more »